communityacquir
pneumonia
cap
common
diseas
may
becom
sever
lead
admiss
intens
care
unit
icu
cap
etiolog
usual
bacteri
howev
caus
role
respiratori
virus
emerg
recent
multiplex
polymeras
chain
reaction
mpcr
kit
screen
larg
panel
respiratori
virus
nowaday
avail
clinic
practic
use
within
sever
studi
among
adult
icu
patient
cap
high
rate
posit
report
strong
variat
distribut
viral
speci
accord
popul
season
geograph
area
howev
caus
role
respiratori
virus
identifi
respiratori
tract
pneumonia
still
debat
sinc
respiratori
virus
might
present
asymptomat
adult
subject
experiment
data
focus
virusbacteria
interact
respiratori
tract
infect
support
pathogen
role
respiratori
virus
pneumonia
mice
coinfect
influenza
pneumonia
l
pneumophila
aureu
impair
antiinfluenza
immun
respons
increas
mortal
similar
synergist
result
obtain
pneumonia
respiratori
syncyti
viru
pneumonia
rhinoviru
human
pathogen
role
respiratori
virus
virusbacteria
coinfect
patient
remain
unclear
conduct
comprehens
observ
studi
among
adult
icu
patient
cap
compar
clinic
characterist
biolog
present
outcom
accord
presenc
viru
respiratori
tract
conduct
retrospect
monocent
observ
studi
icu
bichat
claud
bernard
univers
hospit
pari
franc
studi
period
consecut
patient
undergon
mpcr
respiratori
tract
within
hour
follow
icu
admiss
screen
medic
record
independ
review
two
physician
patient
final
diagnosi
pneumonia
includ
see
definit
popul
select
addit
file
icu
admiss
icu
stay
data
regard
demograph
comorbid
clinic
examin
laboratori
radiolog
find
microbiolog
investig
therapeut
manag
collect
detail
see
addit
file
mortal
defin
death
caus
within
day
hospit
pneumonia
sever
assess
pneumonia
sever
index
psi
simplifi
acut
physiolog
score
sap
ii
respiratori
tract
specimen
underw
gram
stain
quantit
cultur
bacteri
pathogen
urin
antigen
test
pneumonia
l
pneumophila
use
binaxnow
kit
aler
jouy
en
josa
franc
immunoglobulin
ig
antibodi
test
c
pneumonia
pneumonia
consid
posit
igm
antibodi
identifi
signific
increas
igg
antibodi
observ
pair
serum
sampl
respiratori
mpcr
perform
either
nasopharyng
np
swab
lower
respiratori
tract
lrt
specimen
usual
bronchoalveolar
lavag
fluid
otherwis
endotrach
aspir
studi
period
differ
mpcr
kit
use
detail
see
addit
file
pathofind
maastricht
netherland
filmarray
respiratori
panel
biofir
diagnost
salt
lake
citi
ut
usa
could
detect
bocaviru
differenti
rhinoviru
enteroviru
therefor
rhinoviru
enteroviru
result
group
picornaviru
rhinoviru
either
blood
sampl
bronchoalveolar
lavag
fluid
cytomegaloviru
pcr
use
cmv
kit
argen
verniol
franc
kit
qiagen
hilden
germani
herpex
simplex
viru
pcr
use
hsv
roch
basel
switzerland
bacterium
consid
caus
pathogen
pneumonia
bacterium
fulfil
least
one
criterion
detail
see
addit
file
viru
identifi
pcr
alway
consid
caus
pathogen
pneumonia
pneumonia
defin
bacteri
microbiolog
investig
reveal
least
one
bacterium
viru
ii
viral
microbiolog
investig
reveal
least
one
viru
bacterium
iii
mix
virusbacteria
microbiolog
investig
reveal
least
one
viru
one
bacterium
iv
etiolog
microbiolog
investig
reveal
viru
bacterium
primari
endpoint
identifi
present
prognosisspecif
featur
virusbacteria
coinfect
patient
comparison
focus
microbiolog
data
biolog
find
radiolog
pattern
admiss
icu
cours
hospit
outcom
composit
criterion
name
complic
cours
includ
hospit
death
mechan
ventil
day
second
endpoint
describ
epidemiolog
respiratori
virus
adult
patient
admit
icu
cap
patient
cluster
four
group
accord
microbiolog
etiolog
pneumonia
bacteri
viral
mix
etiolog
better
control
impact
bacteri
pathogen
main
find
also
design
subgroup
analysi
compar
patient
bacteri
mix
viralbacteri
cap
match
bacteri
pathogen
one
bacterium
identifi
case
sought
control
bacteri
combin
continu
data
express
median
first
third
quartil
compar
use
kruskallw
test
follow
pairwis
mannwhitney
test
categor
data
express
number
percentag
evalu
use
chisquar
test
fisher
exact
test
p
valu
less
consid
signific
univari
logist
regress
clinic
relev
variabl
use
identifi
variabl
associ
complic
cours
multivari
condit
logist
regress
includ
variabl
p
valu
less
previou
step
use
identifi
variabl
independ
associ
complic
cours
similar
statist
analys
perform
identifi
variabl
independ
associ
hospit
death
mechan
ventil
day
survivor
day
quantit
variabl
valid
loglinear
assumpt
transform
categor
variabl
accord
median
valu
miss
data
imput
median
frequent
valu
accuraci
final
model
test
use
area
receiv
oper
characterist
curv
analysi
hosmerlemeshow
chisquar
test
addit
multivari
condit
logist
regress
limit
bacteri
mix
group
perform
search
specif
associ
virusbacteria
coinfect
complic
cours
comparison
subgroup
analysi
bacteriamatch
patient
involv
univari
condit
logist
regress
follow
multivari
condit
logist
regress
assess
associ
microbiolog
diagnosi
complic
cours
adjust
clinic
relev
variabl
analys
perform
use
sa
softwar
packag
sa
institut
cari
nc
usa
octob
june
patient
screen
fig
final
studi
group
consist
patient
men
age
year
sap
ii
tabl
one
third
refer
medic
ward
anoth
icu
median
psi
score
hospit
admiss
pneumonia
consid
health
careassoci
pneumonia
nearli
half
patient
least
one
factor
immunosuppress
present
patient
microbiolog
investig
display
addit
file
tabl
microbiolog
find
display
tabl
mpcr
perform
np
swab
exclus
n
lrt
specimen
exclus
n
n
n
respiratori
tract
specimen
bacteri
cultur
obtain
patient
patient
respiratori
tract
specimen
obtain
sputum
near
half
patient
n
receiv
antibiot
prior
referr
microbiolog
document
obtain
patient
least
one
bacterium
identifi
patient
least
one
viru
patient
bacteri
document
obtain
patient
expos
antibiot
prior
referr
compar
antibioticsexpos
patient
p
pneumonia
commonli
identifi
bacterium
found
patient
patient
pneumonia
cultur
blood
five
patient
patient
one
bacteri
speci
identifi
taken
togeth
pseudomona
aeruginosa
enterobacteriacea
speci
identifi
nine
patient
bacteri
group
nine
patient
mix
group
influenza
virus
picornaviru
rhinoviru
commonli
identifi
virus
found
patient
respect
nine
patient
one
viru
identifi
patient
undergon
mpcr
np
swab
lrt
specimen
mpcr
discord
ten
patient
includ
eight
patient
np
mpcr
posit
lrt
mpcr
neg
two
patient
np
mpcr
neg
lrt
mpcr
posit
four
studi
group
differ
term
demograph
comorbid
condit
chronic
immunosuppress
hcap
factor
incid
transfer
anoth
ward
antibiot
referr
tabl
microbiolog
investig
also
similar
addit
file
tabl
pneumonia
predomin
bacterium
bacteri
mix
group
tabl
one
patient
infect
extendedspectrum
betalactamaseproduc
enterobacteriacea
fourteen
patient
infect
intracellular
bacteria
includ
l
pneumophila
c
pneumonia
pneumonia
two
viral
coinfect
influenza
virus
commonli
virus
viral
group
wherea
picornaviru
rhinoviru
influenza
virus
equal
predomin
mix
group
incid
shock
higher
patient
document
bacteri
infect
bacteri
mix
group
respect
comparison
patient
viral
etiolog
group
respect
p
tabl
overal
patient
mix
pneumonia
display
higher
diseas
sever
hospit
icu
admiss
higher
rate
psi
class
ivv
hospit
referr
vs
bacteri
viral
etiolog
group
respect
p
increas
sap
ii
vs
bacteri
viral
etiolog
group
respect
p
among
patient
mix
pneumonia
infect
virus
influenza
includ
patient
infect
picornaviru
rhinoviru
virusinfect
patient
display
high
serum
level
creatin
kinas
low
platelet
count
trend
toward
high
incid
alveolarinterstiti
infiltr
chest
xray
addit
file
tabl
signific
differ
observ
group
regard
cardiac
troponin
howev
virusinfect
patient
display
cardiac
troponin
upper
limit
normal
compar
eight
virusuninfect
patient
bacteriainfect
patient
except
one
bacteri
group
one
mix
group
receiv
appropri
antimicrobi
regimen
within
first
hour
icu
admiss
among
influenzainfect
patient
patient
receiv
ozeltamivir
within
first
hour
admiss
icu
complic
cours
frequent
mix
group
compar
bacteri
viral
etiolog
group
p
multivari
analysi
microbiolog
diagnosi
identifi
independ
factor
complic
cours
tabl
microbiolog
diagnosi
independ
associ
hospit
death
addit
file
tabl
mechan
ventil
day
survivor
day
addit
file
tabl
addit
multivari
analysi
limit
bacteri
mix
group
identifi
virusbacteria
coinfect
independ
associ
complic
cours
refer
bacteri
pneumonia
ci
p
tabl
impact
viral
coinfect
similar
influenza
virus
addit
file
tabl
subgroup
analysi
bacteriamatch
patient
confirm
find
addit
file
tabl
retrospect
studi
investig
impact
mix
viralbacteri
coinfect
present
outcom
icu
patient
cap
realtim
mpcr
test
identifi
least
one
viru
respiratori
tract
patient
specif
biolog
radiograph
featur
includ
high
serum
level
creatin
kinas
low
platelet
count
high
incid
alveolarinterstiti
infiltr
observ
patient
present
also
higher
statu
sever
hospit
admiss
higher
frequenc
hemodynam
respiratori
failur
icu
stay
viralbacteri
coinfect
independ
associ
complic
cours
find
confirm
subgroup
analysi
compar
bacteriainfect
virusbacteria
coinfect
patient
studi
one
patient
two
infect
least
one
viru
line
recent
report
icu
ventil
patient
cap
find
illustr
high
yield
aggress
diagnost
strategi
broad
panel
mpcr
respiratori
tract
specimen
elsewher
rate
viral
document
report
adult
icu
patient
cap
slightli
lesser
respiratori
tract
specimen
bacteri
test
recov
high
proport
patient
includ
lrt
specimen
patient
bacteri
document
obtain
patient
rang
studi
icu
patient
cap
interestingli
rate
bacteremia
markedli
lower
usual
observ
might
attribut
high
prereferr
exposur
antibiot
overal
patient
microbiolog
diagnosi
high
rate
line
karhu
colleagu
predomin
virus
influenza
virus
picornaviru
rhinoviru
respect
previou
studi
icu
patient
cap
report
much
lower
rate
influenza
infect
might
explain
low
influenza
vaccin
coverag
popul
unfortun
influenza
vaccin
histori
usual
avail
medic
record
prevent
conclus
point
incid
rhinoviru
consist
previou
report
interestingli
viral
phenotyp
emerg
mainli
character
high
serum
level
creatin
kinas
high
frequenc
alveolarinterstiti
infiltr
chest
xray
yet
report
sinc
previou
work
larg
use
mpcr
icu
patient
cap
specif
record
biolog
radiograph
data
chest
xray
pattern
notabl
ground
glass
opac
consist
previou
data
elev
level
serum
creatin
kinas
could
attribut
rhabdomyolysi
associ
viral
infect
especi
influenza
parainfluenza
virus
trend
toward
high
serum
level
cardiac
troponin
virusinfect
patient
might
suggest
acut
myocardi
injuri
furthermor
alveolarinterstiti
infiltr
could
indic
pulmonari
edema
unfortun
brain
natriuret
peptid
dosag
echocardiogram
data
avail
although
left
ventricular
dysfunct
previous
describ
influenza
infect
virusbacteria
coinfect
observ
one
patient
four
consist
previou
report
identifi
independ
associ
complic
cours
find
origin
sinc
previou
work
studi
cap
patient
requir
icu
admiss
point
relationship
viralbacteri
coinfect
sever
karhu
colleagu
studi
limit
cohort
n
wherea
choi
colleagu
observ
low
rate
virusbacteria
coinfect
patient
cohort
thu
prevent
analysi
outcom
studi
hospit
patient
cap
data
suggest
viralbacteri
coinfect
might
associ
highrisk
class
psi
higher
length
hospit
stay
higher
mortal
specif
pneumoniaeinfluenza
pneumoniaerhinoviru
coinfect
correl
sever
ill
hospit
patient
studi
order
avoid
overinterpret
data
decid
consid
respiratori
virus
homogen
group
pathogen
might
critic
sinc
pathogen
probabl
differ
one
viral
speci
anoth
howev
result
remain
similar
take
account
noninfluenza
virus
studi
larger
popul
may
explor
point
compar
prognosi
cap
patient
accord
type
viru
well
differ
virusbacteria
combin
find
might
therapeut
impact
current
medic
target
noninfluenza
respiratori
virus
avail
clinic
practic
cidofocir
ribavirin
immunoglobulin
novel
antivir
drug
target
mainli
respiratori
syncyti
viru
parainfluenza
viru
shown
promis
result
immunocompromis
patient
human
volunt
whether
upcom
drug
would
interest
virusinfect
cap
patient
requir
icu
admiss
question
identifi
virusbacteria
coinfect
patient
risk
complic
icu
cours
studi
might
explor
potenti
benefit
upcom
antivir
drug
highrisk
popul
studi
sever
limit
first
monocent
studi
gener
result
cautiou
second
studi
includ
patient
pneumonia
requir
icu
admiss
mean
studi
mild
moder
pneumonia
prevent
conclus
popul
third
studi
retrospect
control
microbiolog
investig
definit
mpcr
perform
respiratori
tract
everi
includ
patient
criteria
patient
screen
microbiolog
test
occasion
perform
ie
cytomegaloviru
herp
simplex
viru
pcr
c
pneumonia
pneumonia
antibodi
test
furthermor
retrospect
design
prevent
us
obtain
number
data
rare
report
medic
record
physician
includ
vaccin
histori
symptom
hospit
referr
durat
symptom
icu
admiss
fourth
patient
undergon
mpcr
respiratori
tract
within
hour
follow
icu
admiss
screen
might
suggest
confound
indic
fifth
chose
composit
endpoint
decid
priori
inde
consid
predict
low
hospit
mortal
choos
hospit
death
primari
endpoint
low
frequenc
event
death
would
favor
absenc
signific
differ
group
sixth
made
assumpt
viru
identifi
pcr
caus
pathogen
pneumonia
might
critic
sinc
respiratori
virus
might
present
asymptomat
adult
subject
seventh
almost
half
patient
n
receiv
antibiot
prior
icu
admiss
thu
patient
may
falseneg
find
regard
bacteri
infect
may
fals
includ
viral
group
instead
mix
group
etiolog
group
instead
bacteri
group
virus
frequent
identifi
respiratori
tract
patient
pneumonia
requir
icu
admiss
strong
predomin
influenza
rhinoviru
viralbacteri
coinfect
concern
quarter
patient
associ
impair
radiolog
biolog
present
complic
cours
